Profile

Business Description

GT Biopharma, Inc. (NASDAQ: GTBP) is a clinical stage immuno-oncology company focused on developing innovative therapies based on the Company's proprietary NK cell engager (TriKE®) technology. TriKE® therapeutic agents are targeted immunotherapeutic agents that simultaneously react with natural killer (NK) cells and cancer cells to selectively facilitate the killing of cancer cells.

Company Info

Address:
8000 Marina Blvd
Suite 100
Brisbane, CA 94005

Email:
info@gtbiopharma.com

Industry Classifications

Sector:
Healthcare

Industry:
Medical Diagnostics & Research

NAICS:
Pharmaceutical Preparation Manufacturing (325412)

SIC:
Pharmaceutical Preparations (2834)